In our study, the most frequently mutated genes identified using NGS in the 110 NSCLC patients were EGFR, TP53, LRP1B, FAT1, KMT2D, CREBBP, and RB1. This evidence concerns the gene CREBBP and non-small cell lung carcinoma.